Calithera Biosciences, Inc. (CALA)

Calithera Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Revenue	0	9.75	0	0	22.25
Revenue Growth (YoY)	-	-	-	-	-14.26%
Gross Profit	0	9.75	0	0	22.25
Selling, General & Admin	13.54	20.85	20.37	16.61	13.34
Research & Development	28.53	53.46	71.02	76.29	66.2
Other Operating Expenses	0	50.88	0	0	0
Operating Expenses	42.07	74.31	91.39	92.9	79.54
Operating Income	-42.07	-115.43	-91.39	-92.9	-57.28
Interest Income	0.48	0.35	1.25	3.04	2.65
Interest Expense	-20.78	0	0	0	0
Other Expense / Income	18.84	-	-	-	-
Pretax Income	-39.65	-115.09	-90.14	-89.86	-54.63
Income Tax	-20.78	50.25	-1.61	-3.51	-3.16
Net Income	-18.87	-165.34	-88.52	-86.35	-51.47
Shares Outstanding (Basic)	5	4	3	2	2
Shares Outstanding (Diluted)	5	4	3	2	2
Shares Change	35.17%	7.32%	45.46%	29.25%	11.09%
EPS (Basic)	-3.78	-44.77	-25.73	-36.50	-28.12
EPS (Diluted)	-3.78	-44.77	-25.73	-36.50	-28.12
Free Cash Flow	-43.74	-66.45	-84.37	-78.75	-65.06
Free Cash Flow Per Share	-8.76	-17.99	-24.52	-33.29	-35.55
Gross Margin	-	100.00%	-	-	100.00%
Operating Margin	-	-1183.93%	-	-	-257.40%
Profit Margin	-	-1695.77%	-	-	-231.29%
Free Cash Flow Margin	-	-681.51%	-	-	-292.33%
EBITDA	-43.77	-13.68	-91.39	-92.9	-57.28
EBITDA Margin	-	-140.34%	-	-	-257.40%
Depreciation & Amortization	0.26	0.28	0.36	0.48	0.51
EBIT	-44.02	-13.96	-91.75	-93.37	-57.79
EBIT Margin	-	-143.21%	-	-	-259.67%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.